Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
HOWL
#3650
Werewolf Therapeutics, Inc. Common Stock
0.6
0
-1.64%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
-1.64%
Monthly Change
-11.76%
6 month change
-55.88%
Year Change
-49.15%
Previous Close
0.6
1
Open
0.6
0
Bid
Ask
Low
0.6
0
High
0.6
0
Volume
3
Markets
US Stock Market
Healthcare
HOWL
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2021
2022
2023
2024
TTM
Dividends per share
—
—
—
—
—
Dividend yield %
—
—
—
—
—
Payout ratio %
—
—
—
—
—
News
Werewolf Therapeutics explores sale and strategic alternatives
Werewolf Therapeutics stock falls after announcing 64% workforce reduction
Werewolf Therapeutics receives Nasdaq notice for minimum bid price deficiency
Evnin Luke, Werewolf Therapeutics director, sells $20,942 in Howl stock
Evnin Luke sells Werewolf Therapeutics (HOWL) shares for $53,533
Evnin Luke sells Werewolf Therapeutics (HOWL) stock for $45,882
H.C. Wainwright slashes Werewolf Therapeutics stock price target on pipeline update
Werewolf reports 30% response rate for WTX-124 in melanoma patients
Werewolf Therapeutics (HOWL) Upgraded to Buy: Here's What You Should Know
MPM BioVentures sells Werewolf Therapeutics (HOWL) stock for $183k
Werewolf Therapeutics (HOWL) former 10% owners sell $183k in stock
Evnin Luke sells Werewolf Therapeutics (HOWL) stock for $117k